Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,885

A large crowd of monkeys has been filmed brawling over a pot of yoghurt in a street in Thailand. A fall in tourist numbers amid the Covid-19 outbreak has resulted in far fewer people offering them food. The video was filmed in Lopburi, a city north-east of Bangkok that is famed for its monkey population

How to stop the spread of coronavirus ► https://www.youtube.com/watch?v=3jpXAMwRSu4

Support the Guardian ► https://support.theguardian.com/contribute

Today in Focus podcast ► https://www.theguardian.com/news/series/todayinfocus

The Guardian YouTube network:

The Guardian ► https://www.youtube.com/theguardian

Continue reading “Hungry monkeys brawl over food as coronavirus hits tourism in Thailand” | >

Doctors at the Casey Eye Institute at Oregon Health & Science University in Portland have announced the first-ever use of the revolutionary gene editing tool, CRISPR, inside of a person’s body. The tool was used to modify the genes responsible for a particular form of inherited blindness, and those responsible for the pioneering effort say there is real potential here to not only restore the patient’s vision, but open up a new line of medicines specifically used to target and alter DNA.

In an Associated Press report, which comes via NBC, the companies that make the treatment used in the procedure, including Cambridge, Massachusetts-based Editas Medicine and Dublin-based Allergan, highlighted the possibilities moving forward if the trial proves to be successful. Charles Albright, chief scientific officer at Editas, said that “We literally have the potential to take people who are essentially blind and make them see.”

Scientists at the OHSU @CaseyEye Institute have injected a harmless virus containing #CRISPR gene-editing instructions inside the retinal cells of a patient with a rare form of genetic blindness. @NPR @RobSteinNews https://n.pr/3ar3l3M— OHSU News (@OHSUNews) March 6, 2020

Read more | >

EVANSVILLE, Ind., April 17 (UPI) — As produce sales at grocery stores surge during the coronavirus pandemic, one item is selling particularly well — mushrooms.

During the last week of March, fresh mushroom sales were up 18 percent over the same time last year, compared to an 8 percent rise in overall fresh produce sales, according to the Chicago-based data and analytics firm IRI.

“We take heart in those numbers,” said Eric Davis, a spokesman for the Mushroom Council, an industry group based in Redwood Shores, Calif. “We take heart that we’re in that group of staple items. You look for bright spots during this time, and that is one for us.”

Read more | >

Recent events such as the COVID-19 pandemic and the use of chemical weapons in the Syria conflict have provided a stark reminder of the plethora of chemical and biological threats that soldiers, medical personnel and first responders face during routine and emergency operations.

Personnel safety relies on which, unfortunately, still leaves much to be desired. For example, high breathability (i.e., the transfer of water vapor from the wearer’s body to the outside world) is critical in protective military uniforms to prevent heat-stress and exhaustion when soldiers are engaged in missions in contaminated environments. The same materials (adsorbents or barrier layers) that provide protection in current garments also detrimentally inhibit breathability.

To tackle these challenges, a multi-institutional team of researchers led by Lawrence Livermore National Laboratory (LLNL) scientist Francesco Fornasiero has developed a smart, breathable fabric designed to protect the wearer against biological and chemical warfare agents. Material of this type could be used in clinical and medical settings as well. The work was recently published online in Advanced Functional Materials and represents the successful completion of Phase I of the project, which is funded by the Defense Threat Reduction Agency through the Dynamic Multifunctional Materials for a Second Skin “D[MS]2” program.

Read more | >

A few years after Li Jinxing graduated from college, he returned to his rural hometown to become a flower farmer. The days were long but the routine familiar: rise early and tend to the blossoms in the morning; trim and package those in bloom during the afternoon; deliver the parcels, delicately stacked in trucks, to customers by late evening.

Where the flowers ended up, Li was never quite sure. From his fields in Yunnan province, China, he sold them to national distributors who sold them to flower shops who sold them to end consumers. He imagined the beautiful fruits of his labor brightening up homes around the country. This had been the life work of his family for generations. It all threatened to come to an end with covid-19.

Li, 27, remembers the exact moment he heard about the viral outbreak: it was past midnight on January 20, 2020. The Chinese New Year was only five days away, and he had spent the day harvesting flowers in preparation for the expected holiday bump in sales. As he swiped through Douyin, China’s version of TikTok, he saw a fleeting mention of the disease. Li wasn’t sure what to think. Wuhan was nearly 1,200 miles away—the problem felt distant and intangible. Days later, it snowed on New Year’s Eve, he remembers. He took it as an auspicious sign.

Read more | >

“In the 1960s, Italian media uncovered evidence that the Vatican had invested in entities that conflict directly with the church’s holy mission, including Istituto Farmacologico Serono, a pharmaceutical company that made birth control pills, and Udine, a military weapons manufacturer. There have also been unconfirmed rumor of church money in firearms manufacturer Beretta and companies with activities in gambling and pornography. It has been linked to dealings with Nazi gold during World War II as well.”

How much real estate does the Catholic Church own? What are its equity holdings? These questions, and more, not answered.

Author: Emily StewartPublish date:

Read more | >

There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2.

Since the outbreak began in late 2019, researchers have been racing to learn more about SARS-CoV-2, which is a strain from a family of viruses known as coronavirus for their crown-like shape.

Northeastern chemical engineering professor Thomas Webster, who specializes in developing nano-scale medicine and technology to treat diseases, is part of a contingency of scientists that are contributing ideas and technology to the Centers for Disease Control and Prevention to fight the COVID-19 outbreak.

The idea of using nanoparticles, Webster says, is that the virus behind COVID-19 consists of a structure of a similar scale as his nanoparticles. At that scale, matter is ultra-small, about ten thousand times smaller than the width of a single strand of hair.

Webster is proposing particles of similar sizes that could attach to SARS-CoV-2 viruses, disrupting their structure with a combination of infrared light treatment. That structural change would then halt the ability of the virus to survive and reproduce in the body.

Read more | >